Switch theme
Sign up to access all valuation multiples
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME’s acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
2001
3.8K+
LTM Revenue $6.3B
LTM EBITDA $4.5B
$106B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CME Group has a last 12-month revenue (LTM) of $6.3B and a last 12-month EBITDA of $4.5B.
In the most recent fiscal year, CME Group achieved revenue of $6.1B and an EBITDA of $5.0B.
CME Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CME Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.3B | XXX | $6.1B | XXX | XXX | XXX |
| Gross Profit | $6.3B | XXX | $5.3B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 86% | XXX | XXX | XXX |
| EBITDA | $4.5B | XXX | $5.0B | XXX | XXX | XXX |
| EBITDA Margin | 71% | XXX | 82% | XXX | XXX | XXX |
| EBIT | $4.3B | XXX | $3.9B | XXX | XXX | XXX |
| EBIT Margin | 68% | XXX | 64% | XXX | XXX | XXX |
| Net Profit | $3.8B | XXX | $3.5B | XXX | XXX | XXX |
| Net Margin | 60% | XXX | 58% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $536M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, CME Group's stock price is $289.
CME Group has current market cap of $104B, and EV of $106B.
See CME Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $106B | $104B | XXX | XXX | XXX | XXX | $10.63 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, CME Group has market cap of $104B and EV of $106B.
CME Group's trades at 17.3x EV/Revenue multiple, and 21.0x EV/EBITDA.
Equity research analysts estimate CME Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CME Group has a P/E ratio of 27.2x.
See valuation multiples for CME Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $104B | XXX | $104B | XXX | XXX | XXX |
| EV (current) | $106B | XXX | $106B | XXX | XXX | XXX |
| EV/Revenue | 16.8x | XXX | 17.3x | XXX | XXX | XXX |
| EV/EBITDA | 23.7x | XXX | 21.0x | XXX | XXX | XXX |
| EV/EBIT | 24.5x | XXX | 27.0x | XXX | XXX | XXX |
| EV/Gross Profit | 16.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 27.2x | XXX | 29.5x | XXX | XXX | XXX |
| EV/FCF | 28.2x | XXX | 29.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCME Group's last 12 month revenue growth is 6%
CME Group's revenue per employee in the last FY averaged $1.6M, while opex per employee averaged $0.4M for the same period.
CME Group's rule of 40 is 90% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CME Group's rule of X is 86% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for CME Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 71% | XXX | 82% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | 90% | XXX | 88% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 86% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| ASX | XXX | XXX | XXX | XXX | XXX | XXX |
| Euroxx Securities | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Exchange Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Cboe Global Markets | XXX | XXX | XXX | XXX | XXX | XXX |
| Indian Energy Exchange | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CME Group acquired XXX companies to date.
Last acquisition by CME Group was XXXXXXXX, XXXXX XXXXX XXXXXX . CME Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was CME Group founded? | CME Group was founded in 2001. |
| Where is CME Group headquartered? | CME Group is headquartered in United States of America. |
| How many employees does CME Group have? | As of today, CME Group has 3.8K+ employees. |
| Who is the CEO of CME Group? | CME Group's CEO is Mr. Terrence A. Duffy. |
| Is CME Group publicy listed? | Yes, CME Group is a public company listed on NAS. |
| What is the stock symbol of CME Group? | CME Group trades under CME ticker. |
| When did CME Group go public? | CME Group went public in 2002. |
| Who are competitors of CME Group? | Similar companies to CME Group include e.g. ASX, Euroxx Securities, Athens Exchange Group, Cboe Global Markets. |
| What is the current market cap of CME Group? | CME Group's current market cap is $104B |
| What is the current revenue of CME Group? | CME Group's last 12 months revenue is $6.3B. |
| What is the current revenue growth of CME Group? | CME Group revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of CME Group? | Current revenue multiple of CME Group is 16.8x. |
| Is CME Group profitable? | Yes, CME Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CME Group? | CME Group's last 12 months EBITDA is $4.5B. |
| What is CME Group's EBITDA margin? | CME Group's last 12 months EBITDA margin is 71%. |
| What is the current EV/EBITDA multiple of CME Group? | Current EBITDA multiple of CME Group is 23.7x. |
| What is the current FCF of CME Group? | CME Group's last 12 months FCF is $3.8B. |
| What is CME Group's FCF margin? | CME Group's last 12 months FCF margin is 59%. |
| What is the current EV/FCF multiple of CME Group? | Current FCF multiple of CME Group is 28.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
